When managing Keytruda (pembrolizumab) side effects, it is crucial to consult with healthcare professionals for personalized guidance. Common side effects of Keytruda can include fatigue, cough, nausea, skin rash, decreased appetite, and diarrhea. More serious side effects may also occur, such as lung problems, liver problems, hormone gland problems, kidney problems, and severe skin reactions.

To effectively manage these side effects, it is recommended to communicate openly with healthcare providers about any symptoms experienced during treatment. They may suggest interventions such as medication adjustments, lifestyle modifications, or additional treatments to alleviate side effects. Patients should also adhere to scheduled follow-up appointments to monitor their response to Keytruda and address any emerging concerns promptly.

Furthermore, maintaining a healthy lifestyle by eating a balanced diet, staying hydrated, getting regular exercise, and managing stress can support overall well-being during Keytruda treatment. It is essential to prioritize self-care and seek support from healthcare providers, family, and friends to navigate the challenges associated with immunotherapy treatment effectively.

Cancer patients undergoing immunotherapy, including Keytruda, should be aware of the potential side effects and be proactive in reporting any new or worsening symptoms to their healthcare team promptly. By fostering a collaborative relationship with healthcare providers and staying informed about potential side effects, patients can optimize their treatment experience and achieve the best possible outcomes.

Sources:
[1] https://www.drugpatentwatch.com/p/biologics/tradename/KEYTRUDA
[2] https://www.keytruda.com/immunotherapy-treatment-tips/
[3] https://www.cancer.gov/news-events/cancer-currents-blog/2019/cancer-immunotherapy-investigating-side-effects